BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
3 hedge funds and large institutions have $21.9K invested in BIMI International Medical Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
50% less funds holding
Funds holding: 6 → 3 (-3)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
87% less capital invested
Capital invested by funds: $172K → $21.9K (-$150K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$10.6K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$77K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8K |
| 3 |
BlackRock
New York
|
-$7K |
BIMI Hedge Fund Activity: Q1 2020 in Review
3 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q1 2020, worth a combined $21.9K — down 87% from $172K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BIMI and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $10.6K. The largest seller was Barclays, exiting entirely with an estimated $77K sold.
- 3 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q1 2020, down from 6 in Q4 2019.
- Funds reported $21.9K of BIMI International Medical Inc. Common Stock stock for Q1 2020, down 87% quarter-over-quarter.
- 1 fund opened new BIMI International Medical Inc. Common Stock positions in Q1 2020 and 3 closed out, a net change of -2 holders.
- The largest BIMI International Medical Inc. Common Stock buyer in Q1 2020 was UBS Group, an estimated $10.6K added.
- The largest BIMI International Medical Inc. Common Stock seller in Q1 2020 was Barclays, an estimated $77K sold.
Based on aggregated 13F filings for Q1 2020.